Literature DB >> 11729738

[Population-based study of diabetic retinopathy in Wolfsburg].

L Hesse1, M Grüsser, K Hoffstadt, V Jörgens, P Hartmann, P Kroll.   

Abstract

INTRODUCTION: Since November 1997 the complete documentation of an ophthalmological examination of diabetics has been annually subsidized by the Volkswagen Corporation Health Maintenance Organization (VW-HMO).
METHODS: The results of an annual ophthalmological examination were recorded in a standardised history sheet developed by the Initiative Group for Early Detection of Diabetic Eye Diseases. These data included visual acuity, intraocular pressure, lens status and a description of fundus abnormalities.
RESULTS: Within 26 months ophthalmological examinations of 2,801 patients were completed which represented 4.5% of all VW-HMO insured patients. On average, patients suffered from diabetes for 9.6 years (SD +/- 8.3), artificial intraocular lenses were present in 357 eyes (6.4%) and 1,216 eyes (12.0%) were diagnosed with cataract or posterior capsule opacification impairing visual acuity. Out of 263 patients younger than 40 years old, 18.8% had a mild or moderate and 3.3% a severe non-proliferative diabetic retinopathy (NPDR). A proliferative diabetic retinopathy (PDR) was found in 2.2% of the younger patients. Of 2,228 patients aged 40 years and older, 11.9% had a mild or moderate and 2.6% a severe NPDR. In 0.9% of this group PDR was diagnosed.
CONCLUSIONS: An annual ophthalmological screening based on a survey sheet of the Initiative Group was successfully introduced. For the first time a population-based evaluation on the prevalence of diabetic retinopathy was carried out for inhabitants of a German city. The prevalence of PDR was found to be lower than previously published in comparable studied.

Entities:  

Mesh:

Year:  2001        PMID: 11729738     DOI: 10.1007/s003470170026

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

1.  The economic burden of diabetic retinopathy in Germany in 2002.

Authors:  Michael Happich; Ursula Reitberger; Lusine Breitscheidel; Michael Ulbig; Jessamy Watkins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-04       Impact factor: 3.117

2.  [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

Authors:  F Ziemssen; K Lemmen; B Bertram; H P Hammes; H Agostini
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

3.  The Prevention and Treatment of Retinal Complications in Diabetes.

Authors:  Susanne Gabriele Schorr; Hans-Peter Hammes; Ulrich Alfons Müller; Heinz-Harald Abholz; Rüdiger Landgraf; Bernd Bertram
Journal:  Dtsch Arztebl Int       Date:  2016-12-02       Impact factor: 5.594

4.  [Diabetic retinopathy. Internal medical aspects of an ophthalmologic topic].

Authors:  H-P Hammes
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

5.  [Diabetic retinopathy and maculopathy].

Authors:  H-P Hammes
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

6.  [Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002-2004].

Authors:  M Blum; C Kloos; N Müller; A Mandecka; R Berner; B Bertram; U A Müller
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

7.  Diabetic retinopathy in Oman: a hospital based study.

Authors:  R Khandekar; J Al Lawatii; A J Mohammed; A Al Raisi
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

8.  Prevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia.

Authors:  Ivan Dedov; Oxana Maslova; Yurii Suntsov; Lubov Bolotskaia; Tamara Milenkaia; Lena Besmertnaia
Journal:  Rev Diabet Stud       Date:  2009-08-10

9.  Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRCTN70703138].

Authors:  Thomas Linn; Marion Mann; Markus Mann; Reinhard G Bretzel; Rolf H Boedeker
Journal:  BMC Endocr Disord       Date:  2003-12-10       Impact factor: 2.763

10.  Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database.

Authors:  Hans-Peter Hammes; Reinhard Welp; Hans-Peter Kempe; Christian Wagner; Erhard Siegel; Reinhard W Holl
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.